Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Carcinoma × Dasatinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 49 Precursor Cell Lymphoblastic Leukemia-Lymphoma 46 Leukemia, Myeloid, Chronic-Phase 31 Leukemia 23 Leukemia, Myeloid, Acute 17 Breast Neoplasms 15 Recurrence 12 Prostatic Neoplasms 12 Leukemia, Lymphocytic, Chronic, B-Cell 12 Burkitt Lymphoma 11 Neoplasm Metastasis 10 Blast Crisis 10 Multiple Myeloma 9 Leukemia, Myeloid, Accelerated Phase 9 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 8 Neoplasms 8 Lymphoma, Non-Hodgkin 7 Glioblastoma 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Lung Neoplasms 6 Philadelphia Chromosome 5 Myelodysplastic Syndromes 5 Gliosarcoma 5 Gastrointestinal Stromal Tumors 5 Waldenstrom Macroglobulinemia 4 Squamous Cell Carcinoma of Head and Neck 4 Ovarian Neoplasms 4 Melanoma 4 Lymphoma, Large-Cell, Anaplastic 4

Interventions

Cisplatin 46 Carboplatin 43 pembrolizumab 39 Paclitaxel 38 Gemcitabine 27 Radiotherapy 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 18 Radiotherapy, Intensity-Modulated 17 Docetaxel 17 Specimen Handling 15 Nivolumab 15 Cetuximab 15 Cyclophosphamide 14 durvalumab 13 Fluorouracil 13 130-nm albumin-bound paclitaxel 10 Platinum 9 Bevacizumab 9 osimertinib 8 Sunitinib 8 Sorafenib 8 Radiation 8 Oxaliplatin 8 Irinotecan 8 Everolimus 8 Capecitabine 8 1,2-diaminocyclohexaneplatinum II citrate 8 Ipilimumab 7 Drug Therapy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00564876 2015-02-23

TOP0706

Duke University

Phase 2 Terminated

2 enrolled 4 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡